Evidence map›Paper›PMID 33318204›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Identification of novel targets of azithromycin activity against

Corrie R Belanger, Amy Huei-Yi Lee, Daniel Pletzer, Bhavjinder Kaur Dhillon, Reza Falsafi, Robert E W Hancock

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 51 citations in OpenAlex.

  1. Bridging bench and bedside: translational omics ofEuropean respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  2. Article
  3. Sphingosine synergizes with polymyxin antibiotics againstMicrobiology (Reading, England) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Host-mimicking conditions promoteFrontiers in microbiology · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Alternate Antimicrobial Therapies and Their Companion Tests.Diagnostics (Basel, Switzerland) · 2023
    Review
  18. Nutrient Limitation SensitizesACS infectious diseases · 2023
    Article
  19. Boosting the Antibacterial Activity of Azithromycin on Multidrug-ResistantInternational journal of molecular sciences · 2023
    Article
  20. Spiramycin DisarmsAntibiotics (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Corrie R BelangerCentre for Microbial Diseases and Immunity Research, Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada V6T 1Z4.ORCID 0000-0003-1482-5508
Amy Huei-Yi LeeCentre for Microbial Diseases and Immunity Research, Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada V6T 1Z4.ORCID 0000-0003-3250-3246
Daniel PletzerCentre for Microbial Diseases and Immunity Research, Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada V6T 1Z4.ORCID 0000-0001-5750-7505
Bhavjinder Kaur DhillonCentre for Microbial Diseases and Immunity Research, Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada V6T 1Z4.ORCID 0000-0002-9696-1556
Reza FalsafiCentre for Microbial Diseases and Immunity Research, Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada V6T 1Z4.
Robert E W HancockCentre for Microbial Diseases and Immunity Research, Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada V6T 1Z4; bob@hancocklab.com.
University of British Columbia · CA

Funding

CIHR FDN-154287
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsAzithromycinCell MembraneCulture MediaDrug SynergismGene Expression Regulation, BacterialHumansMacrolidesMicrobial Sensitivity TestsOperonPeptidesPseudomonas aeruginosaSerumAnti-Bacterial AgentsAzithromycinCulture MediaMacrolidesPeptidesantibiotic susceptibilityazithromycinhost-mimicking mediaPseudomonas aeruginosaRNA-Seq

Identifiers

PMID33318204
PMCPMC7777150
OpenAlexW3111947545

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.